fosinopril has been researched along with Chronic Kidney Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geng, Z; Han, Y; Li, H; Wu, J; Xiong, Q; Xu, Y; Xu, Z; Zhou, J | 1 |
| Dai, B; Lv, J; Mei, C; Wang, Y; Xue, C; Yang, B; Yu, S; Zhao, G; Zhou, C | 1 |
1 trial(s) available for fosinopril and Chronic Kidney Diseases
| Article | Year |
|---|---|
Comparison of efficacy and safety between benidipine and hydrochlorothiazide in fosinopril-treated hypertensive patients with chronic kidney disease: protocol for a randomised controlled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; China; Dihydropyridines; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Fosinopril; Glomerular Filtration Rate; Humans; Hydrochlorothiazide; Hypertension; Kidney; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Proteinuria; Renal Insufficiency, Chronic; Research Design; Treatment Outcome; Young Adult | 2017 |
1 other study(ies) available for fosinopril and Chronic Kidney Diseases
| Article | Year |
|---|---|
Chitosan oligosaccharide alleviates renal fibrosis through reducing oxidative stress damage and regulating TGF-β1/Smads pathway.
Topics: Animals; Chitosan; Fibrosis; Fosinopril; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred BALB C; Oligosaccharides; Oxidative Stress; Renal Insufficiency, Chronic; Transforming Growth Factor beta1; Ureteral Obstruction | 2022 |